{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:47Z","timestamp":1792806167700,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04409-2","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:34:32Z","timestamp":1779978872000},"page":"5514-5522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal functional status and prognostic stratification in adrenocortical carcinoma: a single-center retrospective cohort study"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-4356","authenticated-orcid":false,"given":"Fernando","family":"Guerrero-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Tarruella Planas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Weilg Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"S\u00e1nchez Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Monedero de Reynoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ort\u00edz Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Sim\u00f3 Servat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Caballero-Corchuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"P\u00e9rez-Maraver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vilarrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"4409_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","volume":"13","author":"M Fassnacht","year":"2025","unstructured":"Fassnacht M, Puglisi S, Kimpel O, Terzolo M. Adrenocortical carcinoma: a practical guide for clinicians. Lancet Diabetes Endocrinol. 2025;13:438\u201352. https:\/\/doi.org\/10.1016\/S2213-8587(24)00378-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"4409_CR2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-25-0034","volume":"32","author":"M Araujo-Castro","year":"2025","unstructured":"Araujo-Castro M, \u00c1lvarez-Escola C, Caster\u00e0s A, Carmona-Bayonas A, Chiara MD, Hanzu FA, et al. Spanish consensus on the diagnosis and management of adrenocortical carcinoma. Endocr Relat Cancer. 2025;32(5):e250034. https:\/\/doi.org\/10.1530\/ERC-25-0034.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"4409_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.surg.2023.04.070","volume":"175","author":"A Sada","year":"2024","unstructured":"Sada A, Foster TR, Al-Ward R, Sawani S, Charchar H, Pishdad R, et al. The effect of hormonal secretion on survival in adrenocortical carcinoma: a multi-center study. Surg. 2024;175(1):80\u20139. https:\/\/doi.org\/10.1016\/j.surg.2023.04.070.","journal-title":"Surg"},{"issue":"6","key":"4409_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1530\/EJE-18-0450","volume":"179","author":"T Vanbrabant","year":"2018","unstructured":"Vanbrabant T, Fassnacht M, Assie G, Dekkers OM. Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis. Eur J Endocrinol. 2018;179(6):429\u201336. https:\/\/doi.org\/10.1530\/EJE-18-0450.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"4409_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-024-03507-5","volume":"409","author":"C Nastos","year":"2024","unstructured":"Nastos C, Papaconstantinou D, Paspala A, Pararas N, Vryonidou A, Pikouli A, et al. The impact of adrenocortical carcinoma hormone secreting status as a predictor of poor survival: a systematic review and meta-analysis. Langenbecks Arch Surg. 2024;409(1):316. https:\/\/doi.org\/10.1007\/s00423-024-03507-5.","journal-title":"Langenbecks Arch Surg"},{"key":"4409_CR6","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1210\/clinem\/dgaf082","volume":"110","author":"A Carmona-Bayonas","year":"2025","unstructured":"Carmona-Bayonas A, \u00c1lvarez-Escol\u00e1 C, Ballester Navarro I, Hernando Cubero J, Mangas Cruz M\u00c1, Garcia-Centeno R, et al. Does adjuvant mitotane impact cure rates in adrenocortical carcinoma? Insights from the ICARO-GETTHI\/SEEN registry. J Clin Endocrinol Metab. 2025;110:3155\u201367. https:\/\/doi.org\/10.1210\/clinem\/dgaf082.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4409_CR7","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1210\/jc.2005-2730","volume":"91","author":"G Abiven","year":"2006","unstructured":"Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, et al. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab. 2006;91(7):2650\u20135. https:\/\/doi.org\/10.1210\/jc.2005-2730.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4409_CR8","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1210\/clinem\/dgad199","volume":"108","author":"S Puglisi","year":"2023","unstructured":"Puglisi S, Calabrese A, Ferra\u00f9 F, Violi MA, Lagan\u00e0 M, Grisanti S, et al. New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study. J Clin Endocrinol Metab. 2023;108(10):2517\u201325. https:\/\/doi.org\/10.1210\/clinem\/dgad199.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4409_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/jc.2013-2856","volume":"99","author":"T Else","year":"2014","unstructured":"Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2014;99(2):455\u201361. https:\/\/doi.org\/10.1210\/jc.2013-2856.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4409_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.amjsurg.2015.09.020","volume":"211","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, et al. Outcomes after resection of cortisol-secreting adrenocortical carcinoma. Am J Surg. 2016;211(6):1106\u201313. https:\/\/doi.org\/10.1016\/j.amjsurg.2015.09.020.","journal-title":"Am J Surg"},{"issue":"3","key":"4409_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.21873\/anticanres.13224","volume":"39","author":"M Aporowicz","year":"2019","unstructured":"Aporowicz M, Czopnik P, Kubicka E, Piotrowska A, Dziegiel P, Bolanowski M, et al. Minichromosome maintenance proteins MCM-3, MCM-5, MCM-7, and Ki-67 as proliferative markers in adrenocortical tumors. Anticancer Res. 2019;39(3):1151\u20139. https:\/\/doi.org\/10.21873\/anticanres.13224.","journal-title":"Anticancer Res"},{"issue":"4","key":"4409_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1210\/clinem\/dgab866","volume":"107","author":"MR Clay","year":"2022","unstructured":"Clay MR, Pinto EM, Fishbein L, Else T, Kiseljak-Vassiliades K. Pathological and genetic stratification for management of adrenocortical carcinoma. J Clin Endocrinol Metab. 2022;107(4):1159\u201369. https:\/\/doi.org\/10.1210\/clinem\/dgab866.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4409_CR13","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","volume":"26","author":"R Lib\u00e9","year":"2015","unstructured":"Lib\u00e9 R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, et al. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European network for the study of adrenal tumor (ENSAT) study. Ann Oncol. 2015;26(10):2119\u201325. https:\/\/doi.org\/10.1093\/annonc\/mdv329. (ENSAT network.).","journal-title":"Ann Oncol"},{"issue":"10","key":"4409_CR14","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","volume":"5","author":"G Assi\u00e9","year":"2019","unstructured":"Assi\u00e9 G, Jouinot A, Fassnacht M, Lib\u00e9 R, Garinet S, Jacob L, et al. Value of molecular classification for prognostic assessment of adrenocortical carcinoma. JAMA Oncol. 2019;5(10):1440\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1558.","journal-title":"JAMA Oncol"},{"issue":"3","key":"4409_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1210\/jc.2014-3182","volume":"100","author":"F Beuschlein","year":"2015","unstructured":"Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab. 2015;100(3):841\u20139. https:\/\/doi.org\/10.1210\/jc.2014-3182.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"4409_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/modpathol.2013.230","volume":"27","author":"E Duregon","year":"2014","unstructured":"Duregon E, Molinaro L, Volante M, Ventura L, Righi L, Bolla S, et al. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma. Mod Pathol. 2014;27(9):1246\u201354. https:\/\/doi.org\/10.1038\/modpathol.2013.230.","journal-title":"Mod Pathol"},{"issue":"10","key":"4409_CR17","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1007\/s12325-019-01050-0","volume":"36","author":"F Zhang","year":"2019","unstructured":"Zhang F, Zhang F, Liu Z, Wu K, Zhu Y, Lu Y. Prognostic role of Ki-67 in adrenocortical carcinoma after primary resection: a retrospective mono-institutional study. Adv Ther. 2019;36(10):2756\u201368. https:\/\/doi.org\/10.1007\/s12325-019-01050-0.","journal-title":"Adv Ther"},{"issue":"21","key":"4409_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003736","volume":"95","author":"YM Choi","year":"2016","unstructured":"Choi YM, Kwon H, Jeon MJ, Sung TY, Hong SJ, Kim TY, et al. Clinicopathological features associated with the prognosis of patients with adrenal cortical carcinoma: usefulness of the Ki-67 index. Med (Baltim). 2016;95(21):e3736. https:\/\/doi.org\/10.1097\/MD.0000000000003736.","journal-title":"Med (Baltim)"},{"issue":"1","key":"4409_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00428-025-04278-0","volume":"488","author":"G Vocino Trucco","year":"2026","unstructured":"Vocino Trucco G, Duregon E, Papotti M, Volante M. Diagnosis and grading of adrenal cortical carcinoma. Virchows Arch. 2026;488(1):193\u2013210. https:\/\/doi.org\/10.1007\/s00428-025-04278-0.","journal-title":"Virchows Arch"},{"issue":"14","key":"4409_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144829","volume":"14","author":"AJ Goulian","year":"2025","unstructured":"Goulian AJ, Yee DS. Ki-67 as a predictor of metastasis in adrenocortical carcinoma: artificial intelligence insights from retrospective imaging data. J Clin Med. 2025;14(14):4829. https:\/\/doi.org\/10.3390\/jcm14144829.","journal-title":"J Clin Med"},{"issue":"21","key":"4409_CR21","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1111\/jcmm.16936","volume":"25","author":"JJ Baechle","year":"2021","unstructured":"Baechle JJ, Hanna DN, Sekhar KR, Rathmell JC, Rathmell WK, Baregamian N. Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma. J Cell Mol Med. 2021;25(21):10061\u201372. https:\/\/doi.org\/10.1111\/jcmm.16936.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4409_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000469","volume":"8","author":"LS Landwehr","year":"2020","unstructured":"Landwehr LS, Altieri B, Schreiner J, Sbiera I, Weigand I, Kroiss M, et al. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma. J Immunother Cancer. 2020;8(1):e000469. https:\/\/doi.org\/10.1136\/jitc-2019-000469.","journal-title":"J Immunother Cancer"},{"key":"4409_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106462","volume":"238","author":"Y Ishikawa","year":"2024","unstructured":"Ishikawa Y, Yamazaki Y, Tezuka Y, Omata K, Ono Y, Tokodai K, et al. Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: possible effects of in situ disorganized glucocorticoid production on tumor immunity. J Steroid Biochem Mol Biol. 2024;238:106462. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106462.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04409-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04409-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04409-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:01:59Z","timestamp":1792803719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04409-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4409"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04409-2","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}